http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2349316-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
filingDate 2007-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f3be9b08bbcc0ff0a6124cf8692b08e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5addc2cbc9cf9a9c8658e19f21ba9d09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53909c225997982061510899f96a842a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d0612aadf6d111b1cfef5781734f34
publicationDate 2009-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2349316-C1
titleOfInvention Method of pain syndrome treatment for combined craniocerebral trauma
abstract FIELD: medicine. n SUBSTANCE: invention concerns medicine, particularly traumatology, and can be applied in pain syndrome treatment for patients with combined craniocerebral trauma. It involves slow injection of 1 ml of 2% lidocain solution strictly subcutaneously. Injection is located below xiphoid appendix area once per day for 3-5 days. n EFFECT: stable reduction of pain syndrome at minimal anesthetic consumption due to reduced activity of sympathetic nervous system. n 3 ex
priorityDate 2007-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555252

Total number of triples: 18.